My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Deferasirox Pharmathen 360 mg film-coated tablets



Pharmathen S.A.PA1368/021/003

Main Information

Trade NameDeferasirox Pharmathen 360 mg film-coated tablets
Active SubstancesDeferasirox
Dosage FormFilm-coated tablet
Licence HolderPharmathen S.A.
Licence NumberPA1368/021/003

Group Information

ATC CodeV03AC03 deferasirox

Status

License statusAuthorised
Licence Issued04/02/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListDeferasirox 360 mg Film-coated Tablets
Interchangeable List CodeIC0133-180-003
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print